Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...
Use of inferior vena cava (IVC) filters appears to offer no mortality benefit — and may confer a mortality risk — in older adults with pulmonary embolism (PE), a study has shown. The results of the ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into pulmonary embolisms (PE), according to the findings of the ...
(UPDATED) Laser sheaths can safely and successfully enable retrieval of chronic indwelling inferior vena cava (IVC) filters, according to data on 500 people from a long-running, first-in-human study.
(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA ...
BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...
Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...
Most filters -- whether for water or a furnace -- eventually need to be removed or replaced to avoid complications. Blood clot filters, which are implanted in the veins of people at risk of developing ...
Inferior vena cava (IVC) filters are widely used in patients who cannot take blood thinners. The IVC is the largest vein in the body, running from the legs to the chest. IVC filters keep blood clots ...
A federal jury in Dallas found that C.R. Bard Inc.'s IVC blood clot filter is defective in the latest of a series of verdicts that brings the combined winnings for trial lawyers at Dallas-based Martin ...
'This punitive damages award is not based on the harms actually suffered by plaintiff, nor are they proportionate to the actions taken by Rex to bring the [filter] to the market,' the motion said. Two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results